Jennerex

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

450 Sansome St Ste 16, San Francisco, Ca...

Phone Number

(415) 281-8886

Revenue

$7.5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Jennerex

Jennerex Therapeutics specializes in the development and commercialization of targeted oncolytic immunotherapies aimed at treating solid tumors. Their lead product, Pexa-Vec (JX-594), employs multiple mechanisms to combat cancer, particularly focusing on liver, colorectal, and kidney cancers. The company is dedicated to providing innovative treatments for patients with life-threatening cancers, addressing significant unmet medical needs. Through their advanced therapeutic approaches and ongoing clinical trials, Jennerex aims to bring hope and improved outcomes to cancer patients.Explore more
Jennerex's Social MediaPopular SearchesJennerex IncJennerex Biotherapeutics IncJennerexJennerex BiotherapeuticsJernerex IncSIC Code 87,873NAICS Code 54,541Show more

Jennerex Org Chart

PhoneEmail
HH
United States flag for contact location.

Special Advisor To the Board

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Jennerex your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Jennerex

Compare insights from companies similar to Jennerex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Jennerex

$7.5M
11-50
Private
$21.6M
2003
HH
Hoyoung HuhSpecial Advisor To the Board
$19M
51-200
Private
$95M
2016
Stephen Russell, Co-Founder & Chief Executive Officer at Vyriad
Stephen RussellCo-Founder & CEO
$14M
51-200
Private
$31.9M
1997
AG
Andrew GrahamTechnical Operations Vice President, Development
$5.8M
11-50
Private
$7.7M
2014
NT
Natasha TannerResearch Scientist
<$5M
11-50
Public
$406.5M
1998
51-200
Public
$195.4M
1999
PP
Paul PeterPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Jennerex is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Jennerex is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Jennerex.

Jennerex financials insights

Gather financial insights about Jennerex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2013

Unspecified

$21.6M

See All Jennerex's Financials Insights

Jennerex Tech Stack

Jennerex News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Jennerex

What is Jennerex's official website?
Jennerex's official website is www.jennerex.com
What is Jennerex's Revenue?
Jennerex's revenue is $7.5 Million
What is Jennerex's SIC code?
Jennerex's SIC: 87,873
What is Jennerex's NAICS code?
Jennerex's NAICS: 54,541
How many employees does Jennerex have?
Jennerex has 11-50 employees
What industry does Jennerex belong to?
Jennerex is in the industry of: Business Services, Research & Development
What is Jennerex competition?
Jennerex top competitors include: BioEclipse Therapeutics, Vyriad, Candel Therapeutics, Northwest Biotherapeutics
What companies has Jennerex acquired?
Jennerex has acquired the companies: Jennerex
What technology does Jennerex use?
Some of the popular technologies that Jennerex uses are: Cloudflare Website Optimization, Cloudflare CDN, GoDaddy DNS, Cloudflare DNS
How do I contact Jennerex?
Jennerex contact info: Phone number: (415) 281-8886 Website: www.jennerex.com
What does Jennerex do?

Jennerex Therapeutics specializes in the development and commercialization of targeted oncolytic immunotherapies aimed at treating solid tumors. Their lead product, Pexa-Vec (JX-594), employs multiple mechanisms to combat cancer, particularly focusing on liver, colorectal, and kidney cancers. The company is dedicated to providing innovative treatme... nts for patients with life-threatening cancers, addressing significant unmet medical needs. Through their advanced therapeutic approaches and ongoing clinical trials, Jennerex aims to bring hope and improved outcomes to cancer patients.Read More

What are Jennerex social media links?
Jennerex Linkedin page
Is Jennerex a public company?
Jennerex is private company therefore does not currently have an official ticker symbol
See more information about Jennerex

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.